Jingtao Na1, Haifeng Jin2, Xin Wang3, Kan Huang3, Shuang Sun3, Qiang Li3, Wenting Zhang4. 1. Department of Cardiology, The Third Affiliated Hospital of Qiqihar Medical University, No. 27, Taishun Street, Tiefeng District, Qiqihar, 161099, Heilongjiang Province, P.R. China. ndlbfsrlpmzo@163.com. 2. Department of Anatomy, Qiqihar Medical University, Qiqihar, 161006, P.R. China. 3. Department of Cardiology, The Third Affiliated Hospital of Qiqihar Medical University, No. 27, Taishun Street, Tiefeng District, Qiqihar, 161099, Heilongjiang Province, P.R. China. 4. Department of Clinical Pharmacy, The Third Affiliated Hospital of Qiqihar Medical University, Qiqihar, 161099, P.R. China.
Abstract
BACKGROUND: Heart failure (HF) is a clinical syndrome characterized by left ventricular dysfunction or elevated intracardiac pressures. Research supports that microRNAs (miRs) participate in HF by regulating targeted genes. Hence, the current study set out to study the role of HDAC3-medaited miR-18a in HF by targeting ADRB3. METHODS: Firstly, HF mouse models were established by ligation of the left coronary artery at the lower edge of the left atrial appendage, and HF cell models were generated in the cardiomyocytes, followed by ectopic expression and silencing experiments. Numerous parameters including left ventricular posterior wall dimension (LVPWD), interventricular septal dimension (IVSD), left ventricular end diastolic diameter (LVEDD), left ventricular end systolic diameter (LVESD), left ventricular ejection fraction (LVEF), left ventricular fractional shortening (LVFS), left ventricular systolic pressure (LVSP), left ventricular end diastolic pressure (LEVDP), heart rate (HR), left ventricular pressure rise rate (+ dp/dt) and left ventricular pressure drop rate (-dp/dt) were measured in the mice. In addition, apoptosis in the mice was detected by means of TUNEL staining, while RT-qPCR and Western blot analysis were performed to detect miR-18a, HDAC3, ADRB3, cMyb, MMP-9, Collagen 1 and TGF-β1 expression patterns. Dual luciferase reporter assay validated the targeting relationship between ADRB3 and miR-18a. Cardiomyocyte apoptosis was determined by means of flow cytometry. RESULTS: HDAC3 and ADRB3 were up-regulated and miR-18a was down-regulated in HF mice and cardiomyocytes. In addition, HDAC3 could reduce the miR-18a expression, and ADRB3 was negatively-targeted by miR-18a. After down-regulation of HDAC3 or ADRB3 or over-expression of miR-18a, IVSD, LVEDD, LVESD and LEVDP were found to be decreased but LVPWD, LVEF, LVFS, LVSP, + dp/dt, and -dp/dt were all increased in the HF mice, whereas fibrosis, hypertrophy and apoptosis of HF cardiomyocytes were declined. CONCLUSION: Collectively, our findings indicate that HDAC3 silencing confers protection against HF by inhibiting miR-18a-targeted ADRB3.
BACKGROUND:Heart failure (HF) is a clinical syndrome characterized by left ventricular dysfunction or elevated intracardiac pressures. Research supports that microRNAs (miRs) participate in HF by regulating targeted genes. Hence, the current study set out to study the role of HDAC3-medaited miR-18a in HF by targeting ADRB3. METHODS: Firstly, HF mouse models were established by ligation of the left coronary artery at the lower edge of the left atrial appendage, and HF cell models were generated in the cardiomyocytes, followed by ectopic expression and silencing experiments. Numerous parameters including left ventricular posterior wall dimension (LVPWD), interventricular septal dimension (IVSD), left ventricular end diastolic diameter (LVEDD), left ventricular end systolic diameter (LVESD), left ventricular ejection fraction (LVEF), left ventricular fractional shortening (LVFS), left ventricular systolic pressure (LVSP), left ventricular end diastolic pressure (LEVDP), heart rate (HR), left ventricular pressure rise rate (+ dp/dt) and left ventricular pressure drop rate (-dp/dt) were measured in the mice. In addition, apoptosis in the mice was detected by means of TUNEL staining, while RT-qPCR and Western blot analysis were performed to detect miR-18a, HDAC3, ADRB3, cMyb, MMP-9, Collagen 1 and TGF-β1 expression patterns. Dual luciferase reporter assay validated the targeting relationship between ADRB3 and miR-18a. Cardiomyocyte apoptosis was determined by means of flow cytometry. RESULTS:HDAC3 and ADRB3 were up-regulated and miR-18a was down-regulated in HF mice and cardiomyocytes. In addition, HDAC3 could reduce the miR-18a expression, and ADRB3 was negatively-targeted by miR-18a. After down-regulation of HDAC3 or ADRB3 or over-expression of miR-18a, IVSD, LVEDD, LVESD and LEVDP were found to be decreased but LVPWD, LVEF, LVFS, LVSP, + dp/dt, and -dp/dt were all increased in the HF mice, whereas fibrosis, hypertrophy and apoptosis of HF cardiomyocytes were declined. CONCLUSION: Collectively, our findings indicate that HDAC3 silencing confers protection against HF by inhibiting miR-18a-targeted ADRB3.
Authors: Eline L Vegter; Peter van der Meer; Leon J de Windt; Yigal M Pinto; Adriaan A Voors Journal: Eur J Heart Fail Date: 2016-02-11 Impact factor: 15.534
Authors: Michelle W Bloom; Barry Greenberg; Tiny Jaarsma; James L Januzzi; Carolyn S P Lam; Aldo P Maggioni; Jean-Noël Trochu; Javed Butler Journal: Nat Rev Dis Primers Date: 2017-08-24 Impact factor: 52.329
Authors: Eline L Vegter; Daniela Schmitter; Yanick Hagemeijer; Ekaterina S Ovchinnikova; Pim van der Harst; John R Teerlink; Christopher M O'Connor; Marco Metra; Beth A Davison; Daniel Bloomfield; Gad Cotter; John G Cleland; Michael M Givertz; Piotr Ponikowski; Dirk J van Veldhuisen; Peter van der Meer; Eugene Berezikov; Adriaan A Voors; Mohsin A F Khan Journal: Int J Cardiol Date: 2016-09-11 Impact factor: 4.164
Authors: David B Bekelman; Larry A Allen; Connor F McBryde; Brack Hattler; Diane L Fairclough; Edward P Havranek; Carolyn Turvey; Paula M Meek Journal: JAMA Intern Med Date: 2018-04-01 Impact factor: 21.873
Authors: Ekaterina S Ovchinnikova; Daniela Schmitter; Eline L Vegter; Jozine M Ter Maaten; Mattia A E Valente; Licette C Y Liu; Pim van der Harst; Yigal M Pinto; Rudolf A de Boer; Sven Meyer; John R Teerlink; Christopher M O'Connor; Marco Metra; Beth A Davison; Daniel M Bloomfield; Gadi Cotter; John G Cleland; Alexandre Mebazaa; Said Laribi; Michael M Givertz; Piotr Ponikowski; Peter van der Meer; Dirk J van Veldhuisen; Adriaan A Voors; Eugene Berezikov Journal: Eur J Heart Fail Date: 2015-09-08 Impact factor: 15.534
Authors: Eline L Vegter; Ekaterina S Ovchinnikova; Dirk J van Veldhuisen; Tiny Jaarsma; Eugene Berezikov; Peter van der Meer; Adriaan A Voors Journal: Clin Res Cardiol Date: 2017-03-14 Impact factor: 5.460
Authors: Sean Lee Zheng; Fiona T Chan; Adam A Nabeebaccus; Ajay M Shah; Theresa McDonagh; Darlington O Okonko; Salma Ayis Journal: Heart Date: 2017-08-05 Impact factor: 5.994
Authors: Evelyn Gabriela Rusu-Nastase; Ana-Mihaela Lupan; Catalina Iolanda Marinescu; Carmen Alexandra Neculachi; Mihai Bogdan Preda; Alexandrina Burlacu Journal: Front Cardiovasc Med Date: 2022-01-18